Global house dust mite allergy treatment market
Dublin, 02 Dec. 2022 (GLOBE NEWSWIRE) — The Report “Household Dust Mite Allergy Treatment Market by Treatment, By Type, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031” has been added to from ResearchAndMarkets.com offer.
According to Verified Market Research, Global Dust Mite Allergy Treatment Market was valued at USD 1,481.2 Million in 2021 and is projected to reach USD 5,189.3 Million by 2031, registering a CAGR of 13.4% from 2022 to 2031.
The growth of the global house dust mite allergy treatment market is driven by the increase in internal allergens, increased awareness among the population of allergic reactions caused by various types of allergens, and alarming increase in the prevalence of allergic diseases.
According to the Allergy and Asthma Foundation, in March 2020 it was observed that dust mites are the main causes of internal allergies. Moreover, according to the World Health Organization (WHO), in 2020 it was reported that about 70% of allergic reactions are caused by dust mite allergens.
In addition, chronic exposure to dust mites has an impact on the health of the asthmatic population and of people sensitive and allergic to dust mites. Thus, the population diagnosed with allergic rhinitis and asthma is more prone to house dust mite allergy. According to the Center for Disease Control and Prevention (CDC), in 2020 it was reported that approximately 25.2 million people are diagnosed with asthma worldwide.
According to Thermo Fisher Scientific, it has been reported that approximately 90% of the population diagnosed with allergic asthma is sensitized to dust mite allergens. Additionally, according to the Center for Disease Control and Prevention, in 2020, approximately 60 million people were reported to have been diagnosed with allergic rhinitis in the United States. Thus, the increase in the prevalence of asthma and rhinitis is fueling the growth of dust mite allergy treatment. market.
However, the increase in hygiene practices is reducing the occurrence of dust mite allergies, which is hampering the growth of the dust mite treatment market. Also, the lack of proper diagnosis of allergy symptoms caused by house dust mites acts as a key deterrent for the global market. On the contrary, the increased awareness among the population about the various treatments available for allergic diseases is expected to open up new avenues for market expansion. This has further encouraged many key players to enter the emerging markets, thereby providing lucrative opportunities for market growth.
The global dust mite treatment market is segmented into treatment, type, route of administration, distribution channel, and region. Based on treatment, the market is categorized into antihistamine, immunotherapy, and others. By type, it is divided into prescription and over-the-counter. According to the route of administration, it is separated into oral drug and nasal administration. According to the distribution channel, it is differentiated into hospital pharmacy, online pharmacy and retail pharmacy. Regionally, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.
Key market segments
Per treatment
-
Antihistamine
-
Immunotherapy
-
Other
By type
-
Prescription drugs
-
Over-the-counter medications
By administration
-
Oral medication
-
Nasal administration
By distribution channel
-
Hospital pharmacy
-
Online pharmacy
-
Retail pharmacy
By region
-
North America
-
WE
-
Canada
-
Mexico
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
The rest of Europe
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Rest of Asia-Pacific
-
LAMEA
-
Brazil
-
Saudi Arabia
-
South Africa
-
Rest of LAMEA
Main market players
Main results of the study
-
By treatment, the others segment was the largest contributor to the market in 2021.
-
Based on type, prescription drugs segment dominated the market in 2021.
-
According to the route of administration, the oral medications segment showed the highest growth in 2021 and is expected to continue this trend during the forecast period.
-
By distribution channel, hospital pharmacy was the dominant segment in 2021.
-
Regionally, North America generated the largest revenue share in 2021, while Asia-Pacific is expected to grow at the highest CAGR during the forecast period.
Main topics covered:
CHAPTER 1 INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: MITE ALLERGY TREATMENT MARKET, BY TREATMENT
CHAPTER 5: MITE ALLERGY TREATMENT MARKET, BY TYPE
CHAPTER 6: MARKET FOR THE TREATMENT OF MITE ALLERGIES, BY ROUTE OF ADMINISTRATION
CHAPTER 7: MITE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 8: MITE ALLERGY TREATMENT MARKET, BY REGION
CHAPTER 9: CORPORATE LANDSCAPE
CHAPTER 10: COMPANY PROFILES
For more information about this report visit https://www.researchandmarkets.com/r/eevsyo
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
#Global #House #Dust #Mite #Allergy #Treatment #Market #Report #Allergy #Therapeutics #Bayer #GlaxoSmithKline #Johnson #Johnson